Generic name (INN) · Small Molecule
pomaglumetad methionil
pomaglumetad methionil is a generic name (inn) for Pomaglumetad methionil, developed by Eli Lilly and Company.
- Status
- Discontinued for Schizophrenia
- Mechanism
- mGlu2 Agonist
- Developer
- Eli Lilly and Company
Programs
- Pomaglumetad methionil for SchizophreniaDiscontinuedDiscontinued
Also known as
- LY2140023
- LY-2140023
- LY2140023 monohydrate
- DB103
- DB-103
- pomaglumetad
- LY-404039
- 956385-05-0
- (1R,4S,5S,6S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-2lambda6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid hydrate